BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Phase III
Mast Therapeutics (MSTX) Announces New Data Supporting MST-188 In Sickle Cell Disease 4/14/2014  More...
Portola Pharmaceuticals, Inc. Announces Publication Of Phase 3 APEX Study Design And Rationale In American Heart Journal 4/14/2014  More...
Ipsen (IPN.PA) Announces A First Set Of Results On Positive Phase III Clinical Study Of Dysport® In The Treatment Of Adults Suffering From Upper Limb Spasticity At The 8th World Congress For Neurorehabilitation In Istanbul 4/14/2014  More...
Enanta Pharmaceuticals, Inc. Announces Detailed Data From TURQUOISE-II Study In Chronic Hepatitis C Patients With Cirrhosis Being Presented At The European Association For The Study Of The Liver (EASL) Meeting 4/14/2014  More...
Intercept Pharmaceuticals (ICPT) Reports Additional Positive Data From POISE Trial At EASL Late-Breaker Session 4/14/2014  More...
BioAlliance Pharma Announces A New Positive DSMB Recommendation To Continue Its Phase III Clinical Trial With Livatag® In Primary Liver Cancer 4/14/2014  More...
BioAlliance Pharma Announces A New Positive DSMB Recommendation To Continue Its Phase 3 Clinical Trial With Livatag® In Primary Liver Cancer 4/14/2014  More...
AbbVie (ABBV)'s Experimental Hepatitis C Regimen Associated With High Cure Rates In Late-Stage Studies 4/14/2014  More...
Bristol-Myers Squibb Company (BMY)'s Hepatitis C Drug Cures Up To 90 Percent In Phase 3 Study 4/11/2014  More...
Actinium Pharmaceuticals, Inc. (ATNM.OB) Analyst Report: High Potential Emerging Biopharmaceutical Firm Nearing Phase 3 Trial Commencement For Innovative Cancer Treatments 4/11/2014  More...
Biogen Idec, Inc. (Massachusetts) (BIIB)'s Blood Disorder Drug Succeeds In Phase 3 Trial 4/10/2014  More...
Cyclacel Pharmaceuticals, Inc. (CYCC) Release: Independent Investigators Present Non-Clinical Data Providing Rationale For Sapacitabine Combination Treatment With Bcr-Abl Inhibitors In CML 4/10/2014  More...
Gilead Sciences, Inc. (GILD) Announces Results From Study Of Sovaldi® For Retreatment Of Chronic Hepatitis C In Patients Not Cured With Prior Antiviral Therapy 4/10/2014  More...
Alkermes plc (ALKS) Pulls Off Phase 3 Win for Long-Lasting Schizophrenia Drug 4/9/2014  More...
Aegerion Pharmaceuticals, Inc. (AEGR) Initiates Phase 3 Clinical Trial In Japan To Evaluate Lomitapide For Treatment Of Homozygous Familial Hypercholesterolemia (Hofh) 4/9/2014  More...
Forest Laboratories, Inc. (FRX) And Almirall Provide Update On The Fixed Dose Combination Of Aclidinium And Formoterol In The U.S. 4/9/2014  More...
Data Presented At American Association for Cancer Research Support Potential Of Peregrine Pharmaceuticals, Inc. (PPHM)'s PS-Targeting Immunotherapy Bavituximab To Enhance Anti-Tumor And Immune-Stimulating Effects Of Anti-CTLA-4 And Anti-PD-1 Treatments In Models Of Melanoma And Colon Cancer 4/9/2014  More...
Northwest Biotherapeutics (NWBO) Again Sets Feuerstein Record Straight; Corrects His False Claims 4/8/2014  More...
Oncolytics Biotech Inc. (ONC.TO) Announces Additional Data From REO 018 Randomized Study Of REOLYSIN® In Head And Neck Cancers 4/8/2014  More...
Ambit Biosciences Initiation Of Quizartinib QUANTUM-R Phase 3 Trial 4/8/2014  More...
Henry Ford Health System Of Detroit To Enroll And Treat Patients In CEL-SCI (CVM)’s Phase 3 Head And Neck Cancer Clinical Trial 4/8/2014  More...
Data Presented At American Association for Cancer Research Support Potential Of Combining Peregrine Pharmaceuticals, Inc. (PPHM)'s PS-Targeting Immunotherapy Agent Bavituximab With Irradiation In Lung Cancer 4/8/2014  More...
Data From Intercept Pharmaceuticals (ICPT)'s Pivotal Phase 3 POISE Trial Of Its FXR Agonist Obeticholic Acid To Treat Primary Biliary Cirrhosis And Other Key Obeticholic Acid Data To Be Presented At EASL 2014 4/7/2014  More...
EMD Serono Announces Initiation Of Phase III START2 Study With Tecemotide In Stage III Non-Small Cell Lung Cancer 4/7/2014  More...
Pacira Pharmaceuticals, Inc. (PCRX) Release: Exparel Use In Femoral Nerve Block For Total Knee Arthroplasty Further Supported By Additional Data From Phase 3 Pivotal Study, SNDA Submission Planned For Second Quarter 2014 4/7/2014  More...
Oncothyreon Inc. (ONTY) Announces Merck KGaA (MKGAF.PK), Darmstadt, Germany, Initiation Of Phase 3 Start2 Study With Tecemotide In Stage III Non-Small Cell Lung Cancer 4/7/2014  More...
Amgen (AMGN)'s Melanoma Drug Talimogene Laherparepvec Misses Phase 3 Goals 4/4/2014  More...
Santen, Inc. Phase 3 Study Meets Primary Endpoint For The Treatment Of Non-Infectious Posterior Segment Uveitis (NI-PSU) 4/4/2014  More...
Regado Biosciences, Inc. (RGDO) Achieves 1,000-Patient Milestone In Phase 3 Trial Of REG1 4/3/2014  More...
BioDelivery Sciences International (BDSI) Announces Enrollment Of The First Patient In A Phase 3 Clinical Study Of Clonidine Topical Gel For Painful Diabetic Neuropathy 4/3/2014  More...
GlaxoSmithKline (GSK) Halts Late-Stage Lung Cancer Vaccine Trial 4/3/2014  More...
Gilead Sciences, Inc. (GILD)'s Japanese Hepatitis C Trial Meets Goal 4/3/2014  More...
Genentech (RHHBY) Halts Study On Experimental Lung Cancer Drug Metmab 4/2/2014  More...
FDA Awards Fast Track Status To TetraPhase Pharmaceuticals For IV And Oral Formulations Of Eravacycline 4/2/2014  More...
Arizona Cancer Research Alliance & 21st Century Oncology To Enroll Patients In CEL-SCI (CVM)’s Global Phase 3 Head and Neck Cancer Trial 4/2/2014  More...
Collegium Pharmaceutical, Inc. Announces Positive Topline Results Of Clinical Study Evaluating The Effect Of Crushing 4/2/2014  More...
Bayer AG (BAYN.DE) Initiates Phase 3 Trial Of Xofigo® (Radium Ra 223 Dichloride) Injection In Combination With Abiraterone Acetate For Asymptomatic Or Mildly Symptomatic Chemotherapy-Naive Patients With Bone Predominant Metastatic Castration-Resistant Prostate Cancer 4/2/2014  More...
Medivir AB (MVRBF) Release: Two Phase 3 Trials Evaluating Once-Daily Simeprevir And Sofosbuvir In Hepatitis C Infected Patients Have Been Initiated 4/2/2014  More...
ERYtech Pharma Receives Orphan Drug Designation By The FDA For ERY-ASP In Acute Myeloid Leukemia 4/2/2014  More...
Amgen (AMGN)'s Evolocumab Lowers Cholesterol Up To 66 Percent In Pivotal Phase 3 Studies 4/1/2014  More...
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Completion Of Enrollment In Pivotal Phase 3 Trial Of Firdapse™ In Patients With Lambert-Eaton Myasthenic Syndrome 4/1/2014  More...
CEL-SCI (CVM) Reports March 2014 Is Record Month For Patient Enrollment In Phase 3 Head And Neck Cancer Trial 4/1/2014  More...
Novartis AG (NVS) Closes Heart Drug Study Early After Strong Results 4/1/2014  More...
Heron Therapeutics, Inc. (APPA) Initiates Phase 3 Label Expansion Study Of SUSTOL™ 3/31/2014  More...
CytRx Corporation (CYTR) Receives Orphan Medicinal Product Designation From European Commission (EC) For Aldoxorubicin In Soft Tissue Sarcoma 3/31/2014  More...
rEVO Biologics Initiates PRESERVE-1 Phase 3 Clinical Trial For ATryn® In Early-Onset Preeclampsia 3/31/2014  More...
Anacor Pharmaceuticals, Inc. (ANAC) Announces First Patient Enrolled In Phase 3 Trial Of AN2728 In Mild-To-Moderate Atopic Dermatitis 3/31/2014  More...
Synthon Pharmaceuticals Announces Successful Outcome Of The Phase 3 GATE Study With Its Generic Glatiramer Acetate 3/27/2014  More...
Furiex Pharmaceuticals, Inc. (FURX) Confirms Takeda Will Present Additional Data From The EXAMINE Trial At American College of Cardiology’s 63rd Annual Scientific Session 3/27/2014  More...
Novartis AG (NVS)'s Rare Lung Cancer Drug Ceritinib Shows Positive Response In Study 3/27/2014  More...
Exelixis, Inc. (EXEL) Provides Update On Ongoing COMET-1 Phase 3 Pivotal Trial In Men With Metastatic Castration-Resistant Prostate Cancer 3/26/2014  More...
Pfizer Inc. (PFE) Notches Another Successful Phase 3 Trial With Genotropin 3/26/2014  More...
Pfizer Inc. (PFE)'s XALKORI® Beats Chemo For Previously Untreated Patients In Phase 3 Study 3/26/2014  More...
Swedish Orphan Biovitrum Release: Kiobrina Pivotal Phase 3 Study Did Not Meet Primary Endpoint 3/26/2014  More...
Novartis AG (NVS) Shows Off Positive Phase 3 Psoriasis Data 3/25/2014  More...
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Recommendation Of Data Monitoring Committee To Continue Pivotal Phase 3 Clinical Trial For Firdapse™ 3/25/2014  More...
ZS Pharma Announces Start Of Enrollment Of Phase 3 Extended Dosing Study Of ZS-9 In Patients With Hyperkalemia 3/25/2014  More...
CogState Ltd (CGS.AX)'s Technology Chosen For Major Phase 3 Trial Of Alzheimer's Disease Drug 3/25/2014  More...
Galderma Laboratories Announces Positive Results Of Phase 3 Trials Of Investigational Ivermectin 1% Targeting Papulopustular Rosacea 3/24/2014  More...
Bristol-Myers Squibb Company (BMY) To Present Data For Daclatasvir In Multiple Investigational All-Oral Combinations Across Hepatitis C Genotypes At The International Liver Congress™ 3/24/2014  More...
Pfizer Inc. (PFE) Announces Detailed Results Of OPT Compare Phase 3 Study Of Tofacitinib 5 Mg And 10 Mg Twice Daily Compared To High-Dose ENBREL® In Adults With Moderate-To-Severe Chronic Plaque Psoriasis 3/24/2014  More...
CytRx Corporation (CYTR) Initiates Pivotal Global Phase 3 Clinical Trial With Aldoxorubicin For Second-Line Treatment Of Soft Tissue Sarcoma 3/24/2014  More...
Celgene (CELG) Release: Oral OTEZLA® (Apremilast) Demonstrated Clinically Meaningful And Sustained Improvements In Skin, Nail And Scalp Of Adult Patients With Moderate To Severe Plaque Psoriasis 3/24/2014  More...
Bay Area's InterMune, Inc. (ITMN) Gains As Boehringer Ingelheim Corporation's Rival Drug Shows Mixed Results 3/24/2014  More...
Kamada Ltd. (KMDA.TA) To Report Top-Line Data From Phase 2/3 Clinical Trial Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency By Late April Or Early May 3/21/2014  More...
AbbVie (ABBV) Initiates New Clinical Trial To Evaluate HUMIRA® (Adalimumab) For The Treatment Of Fingernail Psoriasis In Patients With Moderate To Severe Chronic Plaque Psoriasis 3/20/2014  More...
GlaxoSmithKline (GSK)'s MAGE-A3 Cancer Vaccine Fails Again In Phase 3 Trial But Testing Continues 3/20/2014  More...
Johnson & Johnson (JNJ)'s Janssen Research & Development Test of Schizophrenia Treatment Shows Positive Results 3/20/2014  More...
TetraPhase Pharmaceuticals Provides Update On Clinical Progress Of Phase 3 Lead Antibiotic Candidate Eravacycline 3/20/2014  More...
Pfizer Inc. (PFE)'s Meningitis Vaccine Wins Breakthrough Status From The FDA 3/20/2014  More...
Emmaus Life Sciences Announces Positive Top-Line Results Of Its Phase 3 Clinical Trial For Sickle Cell Disease 3/19/2014  More...
Novo Nordisk A/S (NVO) Reports Positive Results From First Phase 3 Trial With N8-GP, A Long-Acting Factor VIII For Treatment Of Haemophilia A 3/19/2014  More...
Portola Pharmaceuticals, Inc. Initiates Phase 3 Study Of Andexanet Alfa, Potential First-In-Class Factor Xa Inhibitor Reversal Agent, Under Accelerated Approval Pathway 3/19/2014  More...
Alcobra (ADHD) Announces Enrollment Of First Patient In Phase 3 Clinical Trial For MDX In Adult ADHD 3/18/2014  More...
Amgen (AMGN)'s Talimogene Shines In Phase 3 Melanoma Trial 3/18/2014  More...
Amgen (AMGN) Drug Meets Phase 3 Goals For Those With High Genetic Cholesterol 3/18/2014  More...
Intercept Pharmaceuticals (ICPT) Drug Scores Pivotal Phase 3 Win Against Rare Liver Disease 3/18/2014  More...
Medivir AB (MVRBF) Release: New Phase 3 Data From Once-Daily Simeprevir Presented At The Conference Of The Asian Pacific Association For The Study Of The Liver (APASL) 3/17/2014  More...
Ocular Therapeutix, Inc. Begins Phase 3 Clinical Trial For Its Sustained Release Dexamethasone 3/17/2014  More...
AstraZeneca PLC (AZN) Announces Progress On Global PARTHENON Clinical Trial Program With BRILINTA (Ticagrelor) In High-Risk Cardiovascular Disease Patient Populations In Advance Of American College of Cardiology Scientific Session 3/17/2014  More...
GlaxoSmithKline (GSK), Theravance, Inc. (THRX) Touts Positive Results From Three COPD Phase 3 Studies 3/17/2014  More...
GlaxoSmithKline (GSK) Touts Positive Asthma Drug Results From Two Phase 3 Studies 3/14/2014  More...
Navidea Biopharmaceuticals (NAVB) Announces Presentation Of Lymphoseek® Three-Year Recurrence And Survival Outcomes After Sentinel Lymph Node Biopsy In Patients With Breast Cancer And Melanoma 3/14/2014  More...
CrystalGenomics Announces Positive Results Of Phase 3 Trial Of Polmacoxib (CG100649) In Patients With Osteoarthritis 3/13/2014  More...
Zogenix, Inc. (ZGNX) Falls As Rival Purdue Pharma L.P. Announces Positive Phase 3 Trial Of Abuse-Resistant Pill 3/12/2014  More...
Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX)'s Nexavar Misses Target In Phase 3 Liver Cancer Trial 3/11/2014  More...
Regado Biosciences, Inc. (RGDO) Rockets As FDA Bestows Drug With Fast-Track Status 3/11/2014  More...
Romark Laboratories, L.C. Selects DSG, Inc. For Influenza Study 3/11/2014  More...
Novartis AG (NVS) Drug Jakavi® Gets Tagged As A Potential Blockbuster After Positive Late-Stage Study 3/10/2014  More...
GREER® Investigational Sublingual Allergy Immunotherapy Liquid (SAIL)™ For Short Ragweed Allergies Phase III Data Published In Journal Of Allergy And Clinical Immunology 3/10/2014  More...
Auris Medical AG Announces Enrollment Of First Patient In North American Phase 3 Study Of AM-101 In Treatment Of Acute Peripheral Tinnitus 3/10/2014  More...
Northwest Biotherapeutics (NWBO) Wins Recommendation To Continue With Phase 3 GBM Brain Cancer Study 3/7/2014  More...
Incyte Corporation (INCY) Shows Off Positive Data From Phase 3 Rare Blood Cancer Study 3/7/2014  More...
NewLink Genetics' Independent Review Committee Recommends Study Continuation Without Modification After Completion Of First Interim Analysis Of IMPRESS Phase 3 Pancreatic Cancer Trial With Algenpantucel-L 3/7/2014  More...
RedHill Biopharma Ltd. (RDHL) Provides Update On RHB-102 Development And Intellectual Property 3/7/2014  More...
Alkermes plc (ALKS) Announces Initiation Of ALKS 5461 Pivotal Clinical Program For Treatment Of Major Depressive Disorder 3/6/2014  More...
Bristol-Myers Squibb Company (BMY) Plans Big Lung Cancer Study, Pairing Immunotherapies 3/6/2014  More...
AbbVie (ABBV) To Present Late-Breaker Pearl-3 Study In Patients With Chronic Hepatitis C At The 21st Conference On Retroviruses And Opportunistic Infections 3/5/2014  More...
Kamada Ltd. (KMDA.TA) Initiates Phase 2/3 Clinical Trial Of Glassia To Treat Newly Diagnosed Pediatric Patients With Type 1 Diabetes 3/5/2014  More...
Genmab A/S (GEN.CO) Announces Phase 3 Study Of Daratumumab In Relapsed Or Refractory Multiple Myeloma 3/5/2014  More...
Acucela Inc. Completes Enrollment In The Emixustat Hydrochloride Phase 2b/3 Clinical Trial 3/4/2014  More...
Boehringer Ingelheim Corporation Presents Phase 3 Data For Tiotropium Across Asthma Severities 3/3/2014  More...
LFB S.A. Initiates Global Phase 3 Clinical Trial Of New Coagulation Factor Viia (Recombinant) In Patients With Hemophilia A And B 3/3/2014  More...
Boehringer Ingelheim Corporation Release: ASTHMA: New Phase 3 Data Show Tiotropium* Respimat® Effective Across Asthma Severities 3/3/2014  More...
Cell Therapeutics, Inc. (CTIC) Opens Enrollment For PERSIST-2 Phase 3 Trial Of Pacritinib For Patients With Myelofibrosis Who Have Low Platelet Counts 3/3/2014  More...
Enanta Pharmaceuticals, Inc. Release: PEARL-III Study Results In Patients With Chronic Hepatitis C Presented At The 21st Conference On Retroviruses And Opportunistic Infections (CROI) 3/3/2014  More...
Actelion Ltd. (ALIOF.PK)'s Diarrhea Treatment Gets Fast-Track From The FDA 3/3/2014  More...
Pacira Pharmaceuticals, Inc. (PCRX)'s Painkiller, Exparel, Meets Main Goal In Phase 3 Study 2/28/2014  More...
Phase 2b Results Of Anergis' Lead Compound Allert To Be Presented At 2014 American Academy of Dermatology Annual Meeting In San Diego 2/27/2014  More...
Sinovac Biotech Ltd. (SVA)'s EV71 Vaccine Phase III Clinical Trial Results Published In The New England Journal of Medicine 2/27/2014  More...
FDA Grants Astellas Qualified Infectious Disease Product Designation For Isavuconazole For The Treatment Of Invasive Mucormycosis 2/27/2014  More...
CEL-SCI (CVM) Reports 146 Patients Enrolled In Its Phase 3 Immunotherapy Head And Neck Cancer Trial 2/27/2014  More...
Eisai Inc. (ESALF.PK) Announces Initiation Of A Phase 3 Trial Of Eribulin Mesylate Injection Versus Weekly Paclitaxel In First And Second Lines Of Metastatic Breast Cancer 2/27/2014  More...
Shire plc Release:” New Phase 3 Data For Guanfacine Extended Release (GXR) To Be Presented At European Congress Of Psychiatry 2/27/2014  More...
Bay Area's InterMune, Inc. (ITMN) Hits A Home Run With Pivotal Phase 3 Lung Drug Study Results; Stock Rockets 2/27/2014  More...
Novo Nordisk A/S (NVO) Threatened As Eli Lilly and Company (LLY)'s Experimental Diabetes Drug Succeeds In Study 2/26/2014  More...
XOMA (US) LLC (XOMA) Receives Orphan Drug Designation From U.S. FDA for Pyoderma Gangrenosum 2/25/2014  More...
Bristol-Myers Squibb Company (BMY) Wins FDA Breakthrough Therapy Designation For Chronic Hepatitis C Drug 2/25/2014  More...
Celsion Corporation (CLN) Announces FDA Clearance Of The OPTIMA Study - A Pivotal Phase III Trial Of Thermodox In Primary Liver Cancer 2/24/2014  More...
Onconova Therapeutics Inc. (ONTX) Tanks Following Disappointing Phase 3 Rigosertib Results 2/21/2014  More...
AB Science (AB.PA): Initiation Of A New Phase 3 Study With Masitinib In Prostate Cancer, Following Encouraging Survival Results Obtained In A Phase 2 Study 2/21/2014  More...
Auris Medical AG Announces Enrollment Of First Patient In European Phase 3 Study Of AM-101 In Treatment Of Acute Peripheral Tinnitus 2/21/2014  More...
Isis Pharmaceuticals, Inc. (ISIS) Reports Interim Results From ISIS-SMN Rx Multiple Dose Study In Children With Spinal Muscular Atrophy 2/21/2014  More...
Janssen Research & Development Initiates CREDENCE Study In Patients With Type 2 Diabetes And Diabetic Nephropathy 2/21/2014  More...
CSL Behring Release: First Patient Enrolled In Phase III Of COMPACT, A Study Of Volume-Reduced Subcutaneous C1-INH For Prevention Of Hereditary Angioedema (HAE) Attacks 2/20/2014  More...
Bayer AG (BAYN.DE) Initiates Phase 3 Trial Of Stivarga® (Regorafenib) Tablets In Patients With Colorectal Cancer After Resection Of Liver Metastases 2/20/2014  More...
AB Science (AB.PA): Initiation Of A New Phase 3 Study With Masitinib In Prostate Cancer, Following Encouraging Survival Results Obtained In A Phase 2 Study 2/20/2014  More...
Eli Lilly and Company (LLY)'s Ramucirumab Improves Survival In Phase 3 Trial 2/20/2014  More...
New Phase 2a Trial In The United States And Phase 3 Trial In Kazakhstan Study The Use Of CardioCell's itMSC Therapy For Treating Acute Myocardial Infarction 2/19/2014  More...
Active Biotech AB (BTPC) Release: Change In The Clinical Development Program For Laquinimod 2/19/2014  More...
Insmed Incorporated (INSM) Provides Interim Update From Two-Year, Open-Label Extension Study Of ARIKACE To Treat Pseudomonas Aeruginosa In Cystic Fibrosis Patients 2/19/2014  More...
Vital Therapies, Inc. (VTI) Enrolls First Subject From European Site In VTI-208 2/18/2014  More...
Eleven Biotherapeutics (EBIO) Initiates Pivotal Phase 3 Clinical Study With EBI-005 In Dry Eye Disease 2/18/2014  More...
Ampio Pharmaceuticals, Inc. (AMPE) Completes Enrollment And Dosing In 2nd Pivotal Clinical Trial For Ampion™ (The STEP Study) For Its FDA Biological License Application (BLA) 2/18/2014  More...
Bayer HealthCare Pharmaceuticals (BAYA.F)' Long-Acting Hemophilia Drug Shown To Be Effective 2/18/2014  More...
AstraZeneca PLC (AZN) Chases Demon Disease Cure, Potential To Be A Blockbuster Drug 2/17/2014  More...
GlaxoSmithKline (GSK) Finally Starts Much-Anticipated Phase 3 Study For Rare Disease 2/17/2014  More...
Synageva BioPharma (GEVA) Highlights Sebelipase Alfa And LAL Deficiency Data At The Lysosomal Disease Network (LDN) WORLD Symposium™ 2/14/2014  More...
Zogenix, Inc. (ZGNX)'s Zohydro(™) ER Phase 3 Met Primary, Seconday Endpoints 2/13/2014  More...
Oxygen Biotherapeutics, Inc. (OXBO) Release: Newly Published Cardiac Surgery Study Provides Further Evidence That Levosimendan Significantly Improves Post-Operative Kidney Function 2/13/2014  More...
Syndax Pharmaceuticals Inc. Announces National Cancer Institute And FDA Reach Agreement On A Special Protocol Assessment (SPA) For The Phase 3 Trial Of Entinostat In Patients With Advanced ER+ Breast Cancer 2/13/2014  More...
Merck & Co., Inc. (MRK) Joins Race To Copy Sanofi (France) (SAN.PA)'s Lantus 2/12/2014  More...
Ventrus Biosciences, Inc.  (VTUS) Tanks As Anal Fissure Drug Fails In Trial; Stock Down -63.01% At Market Close (February 12, 2014) 2/12/2014  More...
Cempra's Solithromycin Demonstrates No QT Effects In Thorough QT Study 2/11/2014  More...
Regeneron Pharmaceuticals, Inc. (REGN)'s Diabetic Eye Remedy Drug Impresses In Phase 3 Trial 2/11/2014  More...
OncoGenex Pharmaceuticals Inc. Announces Target Number Of Events Reached In Phase 3 SYNERGY Trial Of Custirsen In Metastatic Castrate-Resistant Prostate Cancer 2/10/2014  More...
Lipocine Inc. Announces First Patient Dosed In Phase 3 Study For Oral Testosterone Replacement Therapy 2/10/2014  More...
Ipsen (IPN.PA) Says Phase 3 Prostate Cancer Drug Study Results Are Positive 2/7/2014  More...
Shire plc Scraps Vyvanse® For Depression After Failed Phase 3 Trials 2/7/2014  More...
Zealand Pharma  (ZEAL.CO) Informs That Sanofi (France) (SAN.PA) Has Announced Initiation Of The Lixilan Phase 3 Clinical Program For The Fixed-Ratio Combination Of Lantus® And Lyxumia® 2/6/2014  More...
Janssen Pharmaceutical Inc. 's ZYTIGA® Now Reimbursed in Quebec For Use Prior To Chemotherapy In Men With Metastatic Prostate Cancer 2/6/2014  More...
GlaxoSmithKline (GSK) Talks Up Its Pipeline 2/6/2014  More...
Ipsen (IPN.PA) Announces Clinical Results Of Dysport® Next Generation (DNG) And Its Intent To File The First Ready-To-Use Liquid Toxin A In Europe And ROW1 2/5/2014  More...
Elusys Therapeutics, Inc. Completes Enrollment In Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, ETI-204, In Adult Volunteers 2/5/2014  More...
Furiex Pharmaceuticals, Inc. (FURX) Shares Double As Irritable Bowel Drug Succeeds In Phase 3 Trials 2/5/2014  More...
ArQule, Inc. (ARQL) Announces Commencement Of Phase 3 Clinical Trial With Tivantinib In Hepatocellular Carcinoma By Partner Kyowa Hakko Kirin In Japan 2/4/2014  More...
Collegium Pharmaceutical Announces Completion of Enrollment in Pivotal Phase 3 Clinical Study for Oxycodone DETERx(R), Its Lead Abuse-Deterrent Development Program 2/4/2014  More...
Rockwell Medical (RMTI) Completes Long-Term Safety Study For Iron Maintenance Drug Triferic(TM) 2/4/2014  More...
Supernus Pharmaceuticals (SUPN) Announces Publication Of Phase III Study (PROSPER) Results On Oxtellar XR® 2/3/2014  More...
Eisai Company, Ltd. (ESALY.PK)'s Lenvatinib Phase 3 Trial Meets Primary Endpoint Of Progression Free Survival In Radioiodine-Refractory Differentiated Thyroid Cancer 2/3/2014  More...
AbbVie (ABBV)'s Interferon-Free Hepatitis C Cocktail Excels In Ph3 Study 2/3/2014  More...
Enanta Pharmaceuticals, Inc. Announces Results From Four All-Oral, Interferon-Free, Phase 3 Studies For The Treatment Of Genotype 1 Hepatitis C Virus Infection 1/31/2014  More...
Amgen (AMGN)'s Cholesterol Fighter, Evolocumab, Succeeds In Fifth Late-Stage Study 1/31/2014  More...
Biothera Further Elucidates The Mechanism Of Action Of Cancer Immunotherapy Imprime PGG 1/30/2014  More...
Medivation, Inc. (MDVN) Prevails Again As Prostate Cancer Drug Impresses In Pre-Chemo Study 1/30/2014  More...
SANUWAVE, Inc. Provides Update On Patient Enrollment - Over 75 Percent Now Enrolled In Pivotal Dermapace Clinical Trial 1/29/2014  More...
Amgen (AMGN) Racks Up Second Successful Phase 3 High Cholesterol Study 1/29/2014  More...
Cell Therapeutics, Inc. (CTIC) Announces GOG Completes Patient Enrollment In GOG-0212 Phase 3 Clinical Trial Of Paclitaxel Poliglumex (Opaxio™) As Maintenance Therapy In Ovarian Cancer 1/28/2014  More...
Nymox Pharmaceutical (NYMX) Provides Update On NX-1207 Phase 3 BPH And Phase 2 Prostate Cancer Clinical Trial Activities 1/28/2014  More...
Pfizer Inc. (PFE)'s Top Lung Cancer Drug Hopeful Fails Two Late-Stage Trials 1/27/2014  More...
Celsion Corporation (CLN)'s Liver Cancer Drug May Extend Survival 1/27/2014  More...
BioDelivery Sciences International (BDSI) Rockets On Positive Late-Stage Pain Treatment Study 1/27/2014  More...
TherapeuticsMD, Inc.  (TXMD) Initiates Phase 3 Clinical Trial Of Its Progesterone Candidate (TX 12-002-HR) For Treatment Of Secondary Amenorrhea 1/24/2014  More...
Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S (LUN.CO) To Present New Data On Brexpiprazole In Major Depression (MDD) At European Congress Of Psychiatry (EPA) 1/24/2014  More...
Amgen (AMGN) Touts Positive Phase 3 Results From High Cholesterol Drug Study 1/24/2014  More...
CEL-SCI (CVM) Receives Government Approval In Serbia To Commence Phase III Clinical Trial Of Multikine In Head And Neck Cancer 1/23/2014  More...
Pfizer Inc. (PFE)'s Back-Pain Medication Meets Primary Phase 3 Goals 1/23/2014  More...
EnVivo Pharmaceuticals, Inc. Initiates COGNITIV AD, A Phase 3 Clinical Trial Program Of Encenicline (EVP-6124) In Alzheimer’s Disease 1/22/2014  More...
Roche (RHHBY)'s Schizophrenia Drug, Bitopertin, Misses Goal In Two Late-Stage Trials 1/22/2014  More...
CytRx Corporation (CYTR) Receives FDA Approval To Extend Aldoxorubicin Dosing Cycles Until Disease Progression In Upcoming Pivotal, Global Phase 3 Trial For Soft Tissue Sarcomas 1/21/2014  More...
KV Pharmaceutical Clinical Study On Reducing The Risk Of Recurrent Preterm Birth Becomes Largest Of Its Kind 1/21/2014  More...
MediVector, Inc. Release: First Patient Enrolled In Northern Hemisphere For Phase 3 Study Of Favipiravir For Influenza 1/17/2014  More...
Ipsen (IPN.PA) Announces At American Society of Clinical Oncology GI That ELECT® Clinical Trial Of Somatuline® In The Control Of Symptoms In GEP-NET1 Patients With Carcinoid Syndrome Met Its Primary Endpoint 1/17/2014  More...
ArQule, Inc. (ARQL) Soars As FDA Panel Favors Continuation Of Liver Cancer Drug Study, Stock Up +6.78% At Market Close (January 17, 2014) 1/17/2014  More...
ProSensa Holding N.V. (RNA) Reports Initial Findings From The Further Clinical Data Analyses Of Drisapersen For The Treatment Of Duchenne Muscular Dystrophy 1/16/2014  More...
Zealand Pharma  (ZEAL.CO) Announces Advance By Sanofi (France) (SAN.PA) Of Lixilan, The Single Injection Lyxumia®/Lantus® Combination Product, Towards Phase 3 Development And A Related Milestone Payment 1/15/2014  More...
AbbVie (ABBV) Announces Initiation Of Pivotal Phase 3 Study Of Veliparib (ABT-888) For Patients With Early-Stage Triple-Negative Breast Cancer 1/15/2014  More...
Collegium Pharmaceutical, Inc. Announces Positive Topline Results Of Human Abuse Potential Study Evaluating Intranasal Administration Of Crushed Oxycodone DETERx®, An Abuse-Deterrent, Extended-Release Product 1/15/2014  More...
Salix Pharmaceuticals, Ltd. (SLXP) Release: Fulyzaq® (Crofelemer) 125 Mg Delayed-Release Tablets Significantly Improves Noninfectious Diarrhea In Adult Patients Living With HIV On ART Therapy 1/14/2014  More...
Spark Therapeutics Achieves Recruitment Goal In Phase 3 Gene Therapy Clinical Study For Inherited Blindness 1/14/2014  More...
Nektar Therapeutics (CA) (NKTR) Release: Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis For BEACON Pivotal Phase 3 Clinical Study In Patients With Metastatic Breast Cancer 1/14/2014  More...
Relypsa, Inc. (RLYP) Provides Corporate Update 1/13/2014  More...
BioMarin Pharmaceutical Inc. (BMRN) Announces Selection Of Factor VIII Gene Therapy Drug Development Candidate BMN 270 For The Treatment Of Hemophilia A 1/13/2014  More...
Andromeda Biotech Announces The Acceptance Of Two Manuscripts For Publication Describing Its Phase 3 DIA-AID 1 Study 1/13/2014  More...
ZS Pharma Announces Positive Results From The Extended Treatment Phase Of Its Phase 3 Trial Of ZS-9 In Patients With Hyperkalemia 1/13/2014  More...
Debiopharm Group Announces Completion of Recruitment For Phase III Clinical Study With Triptorelin 22.5 mg In Central Precocious Puberty 1/13/2014  More...
Dezima Pharma Completes Patient Enrolment for TULIP Phase 2B Study With CETP Inhibitor TA-8995 1/13/2014  More...
Synta Pharmaceuticals (SNTA) Announces Launch Of GANNET53, A Randomized, pan-European Study Of Ganetespib In p53 Mutant, Metastatic Ovarian Cancer 1/10/2014  More...
Synta Pharmaceuticals (SNTA) Announces Initiation Of Three Multicenter, Randomized Phase II/III Trials Of Ganetespib In Acute Myeloid Leukemia (AML) And High Risk Myelodysplastic Syndrome (MDS) 1/10/2014  More...
Immunomedics, Inc. (IMMU) Announces Initiation Of Phase 3 Clinical Trial Of Clivatuzumab Tetraxetan In Patients With Pancreatic Cancer 1/10/2014  More...





 

//-->